NIP
Nicholas Investment Partners Portfolio holdings
AUM
$1.12B
1-Year Return
50.66%
This Quarter Return
-2.08%
1 Year Return
+50.66%
3 Year Return
+286.38%
5 Year Return
+525.06%
10 Year Return
+2,262.45%
AUM
$971M
AUM Growth
-$166M
(-15%)
Cap. Flow
-$191M
Cap. Flow
% of AUM
-19.62%
Top 10 Holdings %
Top 10 Hldgs %
19.56%
Holding
257
New
33
Increased
69
Reduced
52
Closed
50
Top Buys
| 1 |
Health Care Select Sector SPDR Fund
XLV
|
$13.4M |
| 2 |
Guardant Health
GH
|
$10M |
| 3 |
EXL Service
EXLS
|
$7.67M |
| 4 |
Cheesecake Factory
CAKE
|
$6.88M |
| 5 |
Palomar
PLMR
|
$6.85M |
Top Sells
| 1 |
Evercore
EVR
|
$16M |
| 2 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
$14.8M |
| 3 |
TFI International
TFII
|
$14.5M |
| 4 |
Core Scientific
CORZ
|
$13.4M |
| 5 |
FTAI Aviation
FTAI
|
$12.1M |
Sector Composition
| 1 | Industrials | 20.23% |
| 2 | Technology | 20.07% |
| 3 | Healthcare | 16.69% |
| 4 | Consumer Discretionary | 9.79% |
| 5 | Financials | 9.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
101
Citigroup
C
$179B
| $2.91M | 0.3% |
41,000
+1,000
| +3% | +$71K |
|
102
Snowflake
SNOW
$74B
| $2.9M | 0.3% |
+19,837
| New | +$2.9M |
|
103
Verisk Analytics
VRSK
$37.7B
| $2.77M | 0.29% |
+9,307
| New | +$2.77M |
|
104
Williams Companies
WMB
$70.3B
| $2.75M | 0.28% |
46,000
| – | – |
|
105
Astera Labs
ALAB
$31.2B
| $2.74M | 0.28% |
45,850
-103,421
| -69% | -$6.17M |
|
106
KLA
KLAC
$115B
| $2.65M | 0.27% |
3,896
-387
| -9% | -$263K |
|
107
Nova
NVMI
$7.44B
| $2.64M | 0.27% |
14,323
+1,112
| +8% | +$205K |
|
|
MCHPP
108
Microchip Technology Incorporated Depositary Shares Each Representing a 1/20th Interest in a Share of 7.50% Series A Mandatory Convertible Preferred Stock
MCHPP
| – | – |
0
| – | – |
|
109
Vertiv
VRT
$48B
| $2.62M | 0.27% |
36,294
+35
| +0.1% | +$2.53K |
|
110
Moelis & Co
MC
$5.32B
| $2.52M | 0.26% |
+43,101
| New | +$2.52M |
|
111
SPS Commerce
SPSC
$4.15B
| $2.49M | 0.26% |
18,789
-20,450
| -52% | -$2.71M |
|
112
Cloudflare
NET
$73.2B
| $2.49M | 0.26% |
22,109
+11,519
| +109% | +$1.3M |
|
113
Onto Innovation
ONTO
$5B
| $2.38M | 0.25% |
19,646
-21,320
| -52% | -$2.59M |
|
114
Texas Roadhouse
TXRH
$11.3B
| $2.33M | 0.24% |
13,993
+11,820
| +544% | +$1.97M |
|
115
Vera Therapeutics
VERA
$1.4B
| $2.29M | 0.24% |
95,402
-11,403
| -11% | -$274K |
|
116
Annaly Capital Management
NLY
$14B
| $2.17M | 0.22% |
106,805
-33,330
| -24% | -$677K |
|
117
Booz Allen Hamilton
BAH
$12.7B
| $2.16M | 0.22% |
20,698
-897
| -4% | -$93.8K |
|
118
Revolution Medicines
RVMD
$7.28B
| $2.16M | 0.22% |
61,123
-23,606
| -28% | -$835K |
|
119
ConocoPhillips
COP
$120B
| $2.1M | 0.22% |
20,000
| – | – |
|
120
Commault Systems
CVLT
$7.88B
| $2.01M | 0.21% |
+12,744
| New | +$2.01M |
|
121
Planet Labs
PL
$1.96B
| $1.97M | 0.2% |
+583,237
| New | +$1.97M |
|
122
Curtiss-Wright
CW
$18.1B
| $1.97M | 0.2% |
6,194
+16
| +0.3% | +$5.08K |
|
123
Palantir
PLTR
$370B
| $1.86M | 0.19% |
+22,075
| New | +$1.86M |
|
124
MoonLake Immunotherapeutics
MLTX
$3.79B
| $1.83M | 0.19% |
+46,933
| New | +$1.83M |
|
125
CACI
CACI
$10.1B
| $1.83M | 0.19% |
4,979
-5,659
| -53% | -$2.08M |
|